Dicoumarol
Dicoumarol[edit]

Dicoumarol is a naturally occurring anticoagulant that functions as a vitamin K antagonist. It is a derivative of coumarin, a compound found in many plants. Dicoumarol was first discovered in spoiled sweet clover hay, which led to the bleeding disease in cattle known as "sweet clover disease."
History[edit]
The discovery of dicoumarol dates back to the 1920s when farmers noticed that cattle feeding on spoiled sweet clover hay were suffering from severe bleeding. In 1939, Karl Paul Link and his team at the University of Wisconsin identified dicoumarol as the causative agent. This discovery paved the way for the development of warfarin, a widely used anticoagulant in humans.
Mechanism of Action[edit]
Dicoumarol acts by inhibiting the enzyme vitamin K epoxide reductase, which is crucial for the synthesis of vitamin K-dependent clotting factors in the liver. These factors include factor II (prothrombin), factor VII, factor IX, and factor X. By inhibiting their synthesis, dicoumarol reduces the blood's ability to clot, thus acting as an anticoagulant.
Clinical Use[edit]
Although dicoumarol was initially used as an anticoagulant in humans, it has largely been replaced by warfarin due to its more predictable pharmacokinetics and ease of monitoring. However, dicoumarol is still of historical interest and is used in research settings to study the effects of vitamin K antagonism.
Side Effects[edit]
The primary side effect of dicoumarol, like other anticoagulants, is an increased risk of bleeding. This can manifest as bruising, nosebleeds, gastrointestinal bleeding, or more severe hemorrhagic events. Patients on dicoumarol require careful monitoring of their prothrombin time or INR (International Normalized Ratio) to ensure therapeutic levels are maintained without excessive bleeding risk.
Related Compounds[edit]
Dicoumarol is structurally related to other coumarin derivatives, including warfarin and acenocoumarol. These compounds share a similar mechanism of action but differ in their pharmacokinetic properties and clinical applications.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian